相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease
Liuhong Cai et al.
STEM CELLS TRANSLATIONAL MEDICINE (2018)
Hemoglobin disorders: lentiviral gene therapy in the starting blocks to enter clinical practice
Karine Sii-Felice et al.
EXPERIMENTAL HEMATOLOGY (2018)
Hematopoietic Stem Cell Transplantation in Thalassemia
Luisa Strocchio et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells
Robert J. Ihry et al.
NATURE MEDICINE (2018)
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
A. A. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Prevalence of Pre-existing Antibodies to CRISPR-Associated Nuclease Cas9 in the USA Population
Vijaya L. Simhadri et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Cas9 immunity creates challenges for CRISPR gene editing therapies
Julie M. Crudele et al.
NATURE COMMUNICATIONS (2018)
Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with beta-Thalassemia Major
Nikoletta Psatha et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for beta-Thalassemia
Maria Rosa Lidonnici et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling beta AS3 Globin for Gene Therapy for Sickle Cell Disease
Valentina Poletti et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients
Erica B. Esrick et al.
BLOOD ADVANCES (2018)
Gene Therapy Approaches to Hemoglobinopathies
Giuliana Ferrari et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2017)
Peptides derived from evolutionarily conserved domains in Beclin-1 and Beclin-2 enhance the entry of lentiviral vectors into human cells
Saliha Majdoul et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage
Nicole M. Gaudelli et al.
NATURE (2017)
Gene Therapy in a Patient with Sickle Cell Disease
Jean-Antoine Ribeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
RNA editing with CRISPR-Cas13
David B. T. Cox et al.
SCIENCE (2017)
Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
Sachith Mettananda et al.
NATURE COMMUNICATIONS (2017)
Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6
Rasmus O Bak et al.
eLife (2017)
Efficient Ex Vivo Engineering and Expansion of Highly Purified Human Hematopoietic Stem and Progenitor Cell Populations for Gene Therapy
Erika Zonari et al.
STEM CELL REPORTS (2017)
Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing inBone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells
Kai-Hsin Chang et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Vectofusin-1, a potent peptidic enhancer of viral gene transfer forms pH-dependent α-helical nanofibrils, concentrating viral particles
Louic S. Vermeer et al.
ACTA BIOMATERIALIA (2017)
The changing landscape of gene editing in hematopoietic stem cells: a step towards Cas9 clinical translation
Daniel P. Dever et al.
CURRENT OPINION IN HEMATOLOGY (2017)
Measles virus envelope pseudotyped lentiviral vectors transduce quiescent human HSCs at an efficiency without precedent
Camille Levy et al.
BLOOD ADVANCES (2017)
KLF1 directly activates expression of the novel fetal globin repressor ZBTB7A/LRF in erythroid cells
Laura J. Norton et al.
BLOOD ADVANCES (2017)
Molecular Determinants of Vectofusin-1 and Its Derivatives for the Enhancement of Lentivirally Mediated Gene Transfer into Hematopoietic Stem/Progenitor Cells
Saliha Majdoul et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Forced chromatin looping raises fetal hemoglobin in adult sickle cells to higher levels than pharmacologic inducers
Laura Breda et al.
BLOOD (2016)
No evidence for cell activation or brain vaso-occlusion with plerixafor mobilization in sickle cell mice
Erika Choi et al.
BLOOD CELLS MOLECULES AND DISEASES (2016)
Transplantation for thalassemia major: alternative donors
Franco Locatelli et al.
CURRENT OPINION IN HEMATOLOGY (2016)
Optimizing autologous cell grafts to improve stem cell gene therapy
Nikoletta Psatha et al.
EXPERIMENTAL HEMATOLOGY (2016)
Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the βA(T87Q)-Globin Gene
Olivier Negre et al.
HUMAN GENE THERAPY (2016)
Cell and Gene Therapy for the Beta-Thalassemias: Advances and Prospects
Jorge Mansilla-Soto et al.
HUMAN GENE THERAPY (2016)
Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype
Christian Brendel et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Genome-Wide Screening of Retroviral Envelope Genes in the Nine-Banded Armadillo (Dasypus novemcinctus, Xenarthra) Reveals an Unfixed Chimeric Endogenous Betaretrovirus Using the ASCT2 Receptor
Sebastien Malicorne et al.
JOURNAL OF VIROLOGY (2016)
CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells
Megan D. Hoban et al.
MOLECULAR THERAPY (2016)
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P. Dever et al.
NATURE (2016)
Non-genotoxic conditioning for hematopoietic stem cell transplantation using a hematopoietic-cell-specific internalizing immunotoxin
Rahul Palchaudhuri et al.
NATURE BIOTECHNOLOGY (2016)
A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition
Elizabeth A. Traxler et al.
NATURE MEDICINE (2016)
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
Mark A. DeWitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Bcl11a Deficiency Leads to Hematopoietic Stem Cell Defects with an Aging-like Phenotype
Sidinh Luc et al.
CELL REPORTS (2016)
Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted Endonucleases
Carmen F. Bjurstrom et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells
Megan D. Hoban et al.
BLOOD (2015)
Plerixafor plus G-CSF-mobilized CD34+ cells represent an optimal graft source for thalassemia gene therapy
Garyfalia Karponi et al.
BLOOD (2015)
Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells
Fabrizia Urbinati et al.
EXPERIMENTAL HEMATOLOGY (2015)
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
Jianbin Wang et al.
NATURE BIOTECHNOLOGY (2015)
Single-cell transcriptomic reconstruction reveals cell cycle and multi-lineage differentiation defects in Bcl11a-deficient hematopoietic stem cells
Jason C. H. Tsang et al.
GENOME BIOLOGY (2015)
Peripheral Blood Progenitor Cell Mobilization for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation
Hien K. Duong et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs
Anais Girard-Gagnepain et al.
BLOOD (2014)
Reactivation of Developmentally Silenced Globin Genes by Forced Chromatin Looping
Wulan Deng et al.
CELL (2014)
Preclinical Evaluation of Efficacy and Safety of an Improved Lentiviral Vector for the Treatment of β-Thalassemia and Sickle Cell Disease
Olivier Negre et al.
CURRENT GENE THERAPY (2014)
Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel
Emanuele Angelucci et al.
HAEMATOLOGICA (2014)
Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease
Cem Kuscu et al.
NATURE BIOTECHNOLOGY (2014)
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Pablo Tebas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Nuclease-mediated gene editing by homologous recombination of the human globin locus
Richard A. Voit et al.
NUCLEIC ACIDS RESEARCH (2014)
CRISPR/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences
Yanni Lin et al.
NUCLEIC ACIDS RESEARCH (2014)
Concurrent Measures of Fusion and Transduction Efficiency of Primary CD34+Cells with Human Immunodeficiency Virus 1-Based Lentiviral Vectors Reveal Different Effects of Transduction Enhancers
Dina Ingrao et al.
HUMAN GENE THERAPY METHODS (2014)
Engraftment and Lineage Potential of Adult Hematopoietic Stem and Progenitor Cells Is Compromised Following Short-Term Culture in the Presence of an Aryl Hydrocarbon Receptor Antagonist
Angel Gu et al.
HUMAN GENE THERAPY METHODS (2014)
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
Steven Lin et al.
ELIFE (2014)
β-globin gene transfer to human bone marrow for sickle cell disease
Zulema Romero et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Infectivity enhancement of different HIV-1-based lentiviral pseudotypes in presence of the cationic amphipathic peptide LAH4-L1
David Fenard et al.
JOURNAL OF VIROLOGICAL METHODS (2013)
Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates
Frederic B. Piel et al.
LANCET (2013)
CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity
Thomas J. Cradick et al.
NUCLEIC ACIDS RESEARCH (2013)
LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis virus
Danit Finkelshtein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Combining gene therapy and fetal hemoglobin induction for treatment of β-thalassemia
Laura Breda et al.
EXPERT REVIEW OF HEMATOLOGY (2013)
Hematopoietic Stem Cell Mobilization for Gene Therapy of Adult Patients With Severe beta-Thalassemia: Results of Clinical Trials Using G-CSF or Plerixafor in Splenectomized and Nonsplenectomized Subjects
Evangelia Yannaki et al.
MOLECULAR THERAPY (2012)
Therapeutic Hemoglobin Levels after Gene Transfer in β-Thalassemia Mice and in Hematopoietic Cells of β-Thalassemia and Sickle Cells Disease Patients
Laura Breda et al.
PLOS ONE (2012)
Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer
Andrew Wilber et al.
BLOOD (2011)
Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities
Andrew Wilber et al.
BLOOD (2011)
Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease
Jizhong Zou et al.
BLOOD (2011)
Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease
Marco Andreani et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Correction of β-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients
Emanuela Anna Roselli et al.
EMBO MOLECULAR MEDICINE (2010)
A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E
Manit Nuinoon et al.
HUMAN GENETICS (2010)
Cocal-pseudotyped Lentiviral Vectors Resist Inactivation by Human Serum and Efficiently Transduce Primate Hematopoietic Repopulating Cells
Grant D. Trobridge et al.
MOLECULAR THERAPY (2010)
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Marina Cavazzana-Calvo et al.
NATURE (2010)
Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin
Joseph Borg et al.
NATURE GENETICS (2010)
Global epidemiology of haemoglobin disorders and derived service indicators
Bernadette Modell et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of β-thalassemia
Annarita Miccio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and Amelioration of the phenotype of β-thalassemia
Manuela Uda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific Repressor BCL11A
Vijay G. Sankaran et al.
SCIENCE (2008)
Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis
Trista E. North et al.
NATURE (2007)
Molecular therapies in β-thalassaemia
Lynn Quek et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics
Stefan Fruehauf et al.
EXPERIMENTAL HEMATOLOGY (2006)
Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins
XY Zhang et al.
JOURNAL OF VIROLOGY (2004)
Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation
HE Davis et al.
BIOPHYSICAL JOURNAL (2004)
Successful correction of the human β-thalassemia major phenotype using a lentiviral vector
G Puthenveetil et al.
BLOOD (2004)
Correction of a mouse model of sickle cell disease:: lentiviral/antisickling β-globin gene transduction of unmobilized, purified hematopoietic stem cells
DN Levasseur et al.
BLOOD (2003)
Permanent and panerythroid correction of murine β thalassemia by multiple lentiviral integration in hematopoietic stem cells
S Imren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Polybrene increases retrovirus gene transfer efficiency by enhancing receptor-independent virus adsorption on target cell membranes
HE Davis et al.
BIOPHYSICAL CHEMISTRY (2002)
Correction of sickle cell disease in transgenic mouse models by gene therapy
R Pawliuk et al.
SCIENCE (2001)
Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/β+ thalassemia
A Wei et al.
BLOOD (2001)
Fatal sickle cell crisis after granulocyte colony-stimulating factor administration
BK Adler et al.
BLOOD (2001)
Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin
C May et al.
NATURE (2000)
分享论文
